Esperion Therapeutics, Inc.

ESPR · Nasdaq · SIC 2834: Pharmaceutical Preparations
260
SEC Filings

Business Summary

Overview Esperion is a commercial stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. We have developed and are commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease, or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. Through commercial execution, international partnerships and collab...

Next Earnings

Q2 FY2026 — expected 2026-08-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionESPRdiscussed_in_filing Cybersecurity
topic_mentionESPRdiscussed_in_filing Trusted Computing
topic_mentionESPRdiscussed_in_filing Blockchain & Crypto
topic_mentionESPRdiscussed_in_filing Regulation
topic_mentionESPRdiscussed_in_filing Healthcare & Bio
topic_mentionESPRdiscussed_in_filing Sovereign & Government
topic_mentionESPRdiscussed_in_filing Cybersecurity
topic_mentionESPRdiscussed_in_filing Trusted Computing
topic_mentionESPRdiscussed_in_filing Blockchain & Crypto
topic_mentionESPRdiscussed_in_filing Regulation
topic_mentionESPRdiscussed_in_filing Healthcare & Bio
topic_mentionESPRdiscussed_in_filing Sovereign & Government
topic_mentionESPRdiscussed_in_filing Cybersecurity
topic_mentionESPRdiscussed_in_filing Trusted Computing
topic_mentionESPRdiscussed_in_filing Blockchain & Crypto
topic_mentionESPRdiscussed_in_filing Regulation
topic_mentionESPRdiscussed_in_filing Healthcare & Bio
topic_mentionESPRdiscussed_in_filing Sovereign & Government
topic_mentionESPRdiscussed_in_filing Cybersecurity
topic_mentionESPRdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001628280-26-016522EDGAR109K words
2025-03-072024-12-310001628280-25-011154EDGAR
2024-02-272023-12-310001628280-24-007066EDGAR
2023-02-212022-12-310001628280-23-004167EDGAR
2022-02-222021-12-310001628280-22-003263EDGAR
2021-02-232020-12-310001628280-21-002865EDGAR
2020-02-272019-12-310001104659-20-026203EDGAR
2019-02-282018-12-310001047469-19-000791EDGAR
2018-02-202017-12-310001047469-18-000899EDGAR
2017-02-222016-12-310001047469-17-000831EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001628280-25-050165EDGAR34K words
2025-08-132025-06-300001628280-25-040139EDGAR
2025-05-082025-03-310001628280-25-023498EDGAR
2024-11-072024-09-300001628280-24-046307EDGAR
2024-08-122024-06-300001628280-24-036762EDGAR
2024-05-072024-03-310001628280-24-020862EDGAR
2023-11-072023-09-300001628280-23-037195EDGAR
2023-08-012023-06-300001628280-23-026358EDGAR
2023-05-092023-03-310001628280-23-016646EDGAR
2022-11-012022-09-300001628280-22-027479EDGAR
2022-08-022022-06-300001628280-22-020111EDGAR
2022-05-032022-03-310001628280-22-011885EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001628280-26-023196EDGAR77K words
2026-03-100001628280-26-016230EDGAR
2026-03-030001628280-26-013552EDGAR
2026-01-120001628280-26-001764EDGAR
2025-11-060001628280-25-049866EDGAR
2025-11-040001628280-25-048557EDGAR
2025-10-080001104659-25-097992EDGAR
2025-10-070001104659-25-097506EDGAR
2025-08-050001628280-25-037601EDGAR
2025-07-010001628280-25-033612EDGAR

260 total filings indexed. 228 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001434868
TickerESPR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 371e24bf5c1ce3a216347bdbd72374ded5503886dfed1af71bf729a37579cf2a
parent: c0531d3d99cb04e1ab825a3bca0e69fcce0afb784a73dd493b94b3059b911436
content hash: bdfbe681cc251912ad282603423fe112c45aeff0db83fc85ca82760ec348f4e0
signed: 2026-04-13T04:44:54.750Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf